Literature DB >> 10375549

T cell co-stimulatory molecules other than CD28.

T H Watts1, M A DeBenedette.   

Abstract

CD28 is the primary co-stimulatory receptor for inducing high-level IL-2 production and survival of naïve CD4(+) T cells. While no other cell surface receptor can be considered fully redundant with CD28, recent developments suggest that additional co-stimulatory pathways have preferential effects at different stages of T cell activation, on different subsets of T cells or contribute to the development of different effector functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375549     DOI: 10.1016/s0952-7915(99)80046-6

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  47 in total

Review 1.  Activation and inhibition of lymphocytes by costimulation.

Authors:  Kenneth A Frauwirth; Craig B Thompson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 2.  Challenges to achieving clinical transplantation tolerance.

Authors:  A D Salama; G Remuzzi; W E Harmon; M H Sayegh
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Authors:  Josie Ursini-Siegel; Sean Cory; Dongmei Zuo; William R Hardy; Elton Rexhepaj; Sonya Lam; Babette Schade; Karin Jirstrom; Eva Bjur; Ciriaco A Piccirillo; David Denardo; Lisa M Coussens; Donal J Brennan; William M Gallagher; Morag Park; Tony Pawson; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

4.  A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cells.

Authors:  Sepideh Khaleghi; Fatemeh Rahbarizadeh; Davoud Ahmadvand; Mohammad J Rasaee; Philippe Pognonec
Journal:  Int J Hematol       Date:  2012-03-11       Impact factor: 2.490

Review 5.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 6.  Genetic analysis of CD28 signaling.

Authors:  Tiffani A Greene; Virginia Smith Shapiro
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Differential T-cell activation by B7-1 expression.

Authors:  Wei Li; Anthony Rosenzweig; Brigitte T Huber
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

8.  Analysis of costimulation by 4-1BBL, CD40L, and B7 in graft rejection by gene expression profiles.

Authors:  Rachel DeFina; Kenneth Christopher; Hongzhen He; Didier Mandelbrot; Yongping Gu; Patricia Finn; David L Perkins
Journal:  J Mol Med (Berl)       Date:  2003-08-22       Impact factor: 4.599

9.  Retrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses.

Authors:  Danya Liu; Eileen M Burd; Craig M Coopersmith; Mandy L Ford
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

Review 10.  SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.

Authors:  Rajesh K Sharma; Esma S Yolcu; Haval Shirwan
Journal:  Expert Rev Vaccines       Date:  2014-03       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.